Apollo Hospitals says merger with Keimed will make it an integrated healthcare company
Summary
The Apollo 24/7-Keimed merger will make Apollo Hospitals an integrated healthcare company and it will also focus on its digital business breaking even in the next six to eight quarters, the company said.
Apollo Hospitals on Saturday, April 27 said the merger of its online pharmacy arm Apollo 24/7 with pharma distributor Keimed will help in a unified pharmacy business and will allow for sustained improvement in margin.
On Friday, April 26, it was reported that Advent International is planning to inject ₹2,475 crore into Apollo Hospitals’ subsidiary, Apollo HealthCo. This investment, amounting to nearly $297 million, marks a strategic manoeuvre by Advent, enabling a merger between Apollo HealthCo’s online pharmacy arm, Apollo 24/7, and pharmaceutical distributor Keimed.
The company said the merger will make Apollo Hospitals an integrated healthcare company and it will also focus on its digital business breaking even in the next six to eight quarters.
The company said Apollo HealthCo will serve 6,000 Apollo Pharmaceis and it will also capture the distribution of around65,000 pharmacies that Keimed distributes to.
The company said it needs CCI and shareholder approval due to Advent and it does not foresee any challenges regarding the same. It added that it was eyeing margin of 7-8% in the 2026-27 financial year.
Apollo Hospitals said 19 entities own Keimed and it has been buying them over a period of time. It said Advent International’s investment of nearly $300 million will suffice the company for the next five years. It added that the cash flow from the company will suffice for its further growth.
Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout
3 Mins Read
Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter